Hello, everyone
This month in our Health in Focus series, we’ll be looking at targeted therapies. Cancer cells behave differently from healthy cells in a number of ways. These behaviours can make them more vulnerable to damage. Targeted therapies are drugs that disrupt this abnormal behaviour, causing the cells to die.
Targeted therapies are usually given in addition to surgery and chemotherapy for ovarian cancer, as maintenance therapies. Their role is to reduce the risk of the cancer recurring and to prolong the time between treatments if it does. This can give people longer periods of feeling well before they next need treatment.
Because targeted therapies are less likely to affect healthy cells, many people find that their side effects are more tolerable than chemotherapy and become easier to manage over time. As with any drug, some people will find them easier to tolerate than others. If you’re experiencing side effects that are difficult to cope with, your team may be able to reduce the dose, which can make them more manageable
Our information booklet about targeted therapies is available at:
ovacome.org.uk/targeted-the...
In this first post in our series on targeted therapies, we will be focusing on drugs that interfere with tumours’ ability to form a blood supply (angiogenesis inhibitors). In particular, we will be looking at bevacizumab (‘Avastin.’) We’ll start by talking about the availability of the drug, how it’s given and its potential side effects and then we’ll give an outline of how it works.
For ovarian cancer, Avastin is available first line in England (via the Cancer Drugs Fund to people who meet certain criteria) and Scotland. It isn’t currently available in Wales and Northern Ireland. Other drugs with a similar way of working are being developed, but at the moment they’re only available for ovarian cancer through clinical trials.
Avastin is usually started alongside chemotherapy and given every three weeks for 18 cycles. Because it affects the blood vessels, Avastin can cause problems with wound healing. Your team will therefore wait until you’ve recovered from your surgery before starting it.
Avastin is given through a drip, so most people will have it in hospital. It normally takes about 30 minutes for each dose, but the first two doses are usually given over 90 and 60 minutes so that the nurses can make sure that you’re tolerating the medication well. Allergic reactions can occur, although they are rare and usually mild.
Side effects of Avastin include low white blood cells, leading to increased risk of infections, low red blood cells (anaemia), causing tiredness and breathlessness, bleeding such as nosebleeds, and high blood pressure. If you suspect that you may have an infection or if you start coughing or vomiting blood, develop unexpected vaginal bleeding or see blood in your stools, you should seek urgent medical advice.
There are other possible side effects of Avastin, and you can find a more detailed list in the links at the end of this post. If you develop any side effects, your team will be able to advise you on how to manage them.
The process Avastin targets is angiogenesis. This is where tumours can only grow to a few millimetres in size before they need their own blood supply in order to continue growing. A tumour gets its blood supply by growing it from a nearby blood vessel. It sends out chemical signals to the cells lining the vessel. The signal binds to the surface of the cell and tells it to grow a new blood vessel towards the tumour.
You can watch a short animation of this at:
youtube.com/watch?v=_qn_noi...
Angiogenesis inhibitors are a type of drug that disrupts this process. The aim of treatment is to deprive the cancer cells of oxygen and nutrients, so the tumour stops growing or shrinks.
One of the chemical signals that cancer cells use is called vascular endothelial growth factor (‘VEGF’). Avastin sticks to the VEGF so that it can’t bind to the blood vessel cells and tell them to grow a new vessel.
You can find more information about Avastin at:
macmillan.org.uk/cancer-inf...
cancerresearchuk.org/about-...
If you would like to share your experiences of Avastin or have any tips on it, please comment on this post. If you would like information or support, please contact our Support Line on 07503 682 311 or email support@ovacome.org.uk.
Best wishes
Julia (Ovacome Support Services Officer)